RTOG study shows improved survival for prostate cancer patients given adjuvant goserelin.

Authors
Journal	Oncology (Williston Park, N.Y.) (Oncology (Williston Park)) Vol. 19 Issue 9 Pg. 1142 (Aug 2005) ISSN: 0890-9091 [Print] United States
PMID	16402596 (Publication Type: News)
Chemical References	Antineoplastic Agents, Hormonal Goserelin
Topics	Antineoplastic Agents, Hormonal (therapeutic use) Chemotherapy, Adjuvant Clinical Trials as Topic Goserelin (therapeutic use) Humans Male Prostatic Neoplasms (drug therapy, mortality, radiotherapy) Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!